Royalty Pharma Plc (RPRX)

26.70 -0.04 (-0.15%)
Close USD Disclaimer
26.72 +0.02 (+0.07%)

Royalty Pharma Plc Company Profile

Equity Type
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 marketed therapies and 10 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neurology, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Contact Information
New York,10022 United States
212 883 0200
Top Executives
Gregory Norden 64 2020 Independent Director
Errol B. De Souza 69 2020 Independent Director
Pablo Gerardo Legorreta 58 1996 Founder, Chairman of the Board & CEO
Catherine M. Engelbert 58 2020 Independent Director
Ted W. Love 64 2020 Independent Director
Rory Balfour Riggs 70 2020 Director
Bonnie L. Bassler 61 2020 Independent Director
Henry A. Fernandez 65 2020 Lead Independent Director
David C. Hodgson 66 2022 Independent Director
Clear All
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Related Articles